B-100 complex can interfere with other medications including but not limited to levodopa, medicines containing oestrogen, hydrazine, certain anti epileptic drugs, phenobaritone, phenytoin, immunosuppressants and some medicines used to treat infections such as isoniazid, pyrazinamide, cycloserne and penicillamine
Metabolic by-product changes: shifts in bacteria can influence microbial metabolites that affect host metabolism
Light Sensitivity Peptides can be degraded by UV light
In animal studies, BPC-157 supports new blood vessel growth, helps cells migrate into injury sites, and balances inflammation
The company urged the FDA to recall all compounded versions of its medicine that include untested additives
Three distinct mechanisms: AMPK activation (MOTS-c), beta-3 adrenergic lipolysis (AOD-9604), and GHRH-stimulated growth hormone release (Tesamorelin)